| Use of a single CAR T cell and several bispecific adapters facilitates eradication of multiple antigenically different solid tumors YG Lee, I Marks, M Srinivasarao, AK Kanduluru, SM Mahalingam, X Liu, ... Cancer research 79 (2), 387-396, 2019 | 117 | 2019 |
| Evaluation of novel tumor-targeted near-infrared probe for fluorescence-guided surgery of cancer SM Mahalingam, SA Kularatne, CH Myers, P Gagare, M Norshi, X Liu, ... Journal of medicinal chemistry 61 (21), 9637-9646, 2018 | 88 | 2018 |
| Design, synthesis, anti-HIV evaluation and molecular modeling of piperidine-linked amino-triazine derivatives as potent non-nucleoside reverse transcriptase inhibitors X Chen, P Zhan, X Liu, Z Cheng, C Meng, S Shao, C Pannecouque, ... Bioorganic & medicinal chemistry 20 (12), 3856-3864, 2012 | 85 | 2012 |
| An adjuvant strategy enabled by modulation of the physical properties of microbial ligands expands antigen immunogenicity F Borriello, V Poli, E Shrock, R Spreafico, X Liu, N Pishesha, C Carpenet, ... Cell 185 (4), 614-629. e21, 2022 | 50 | 2022 |
| A universal dual mechanism immunotherapy for the treatment of influenza virus infections X Liu, B Zhang, Y Wang, HS Haymour, F Zhang, L Xu, M Srinivasarao, ... Nature communications 11 (1), 5597, 2020 | 26 | 2020 |
| Novel piperidinylamino-diarylpyrimidine derivatives with dual structural conformations as potent HIV-1 non-nucleoside reverse transcriptase inhibitors X Chen, X Liu, Q Meng, D Wang, H Liu, E De Clercq, C Pannecouque, ... Bioorganic & medicinal chemistry letters 23 (24), 6593-6597, 2013 | 25 | 2013 |
| Carbonic anhydrase IX-targeted near-infrared dye for fluorescence imaging of hypoxic tumors SM Mahalingam, H Chu, X Liu, CP Leamon, PS Low Bioconjugate Chemistry 29 (10), 3320-3331, 2018 | 24 | 2018 |
| 3D-QSAR and docking studies on piperidine-substituted diarylpyrimidine analogues as HIV-1 reverse transcriptase inhibitors X Liu, X Chen, L Zhang, P Zhan, X Liu Medicinal Chemistry Research 24, 3314-3326, 2015 | 14 | 2015 |
| Design of neuraminidase-targeted imaging and therapeutic agents for the diagnosis and treatment of influenza virus infections X Liu, W Luo, B Zhang, YG Lee, I Shahriar, M Srinivasarao, PS Low Bioconjugate Chemistry 32 (8), 1548-1553, 2021 | 9 | 2021 |
| Targeted delivery of an anti-inflammatory corticosteroid to Ly6C/G-positive cells abates severity of influenza A symptoms N Pishesha, T Harmand, C Carpenet, X Liu, A Bhan, A Islam, ... Proceedings of the National Academy of Sciences 119 (43), e2211065119, 2022 | 6 | 2022 |
| An armed anti-immunoglobulin light chain nanobody protects mice against influenza A and B infections X Liu, T Balligand, C Carpenet, HL Ploegh Science Immunology 8 (84), eadg9459, 2023 | 4 | 2023 |
| Sensitive manipulation of CAR T cell activity using a chimeric endocytosing receptor B Zhang, JV Napoleon, X Liu, Q Luo, M Srinivasarao, PS Low Journal for Immunotherapy of Cancer 8 (2), 2020 | 4 | 2020 |
| Design, Synthesis, and Biological Evaluation of Novel Benzoyl Diarylamine/ether Derivatives as Potential Anti‐HIV‐1 Agents L Zhang, J Guo, X Liu, H Liu, E De Clercq, C Pannecouque, X Liu Chemical Biology & Drug Design 86 (3), 333-343, 2015 | 3 | 2015 |
| Targeted Rejuvenation of Exhausted Chimeric Antigen Receptor T Cells Regresses Refractory Solid Tumors Q Luo, JV Napoleon, X Liu, B Zhang, S Zheng, PS Low Molecular Cancer Research 20 (5), 823-833, 2022 | 2 | 2022 |
| MICA-specific nanobodies for diagnosis and immunotherapy of MICA+ tumors ER Verhaar, A Knoflook, N Pishesha, X Liu, WJC van Keizerswaard, ... Frontiers in Immunology 15, 1368586, 2024 | 1 | 2024 |
| Selective Targeting of Nanobody-Modified Gold Nanoparticles to Distinct Cell Types YH Lee, H Medhi, X Liu, IH Ha, KT Nam, H Ploegh ACS Applied Materials & Interfaces 15 (51), 59258-59268, 2023 | | 2023 |
| Design of Ligand-Targeted Imaging and Therapeutic Agents for the Diagnosis and Treatment of Influenza Virus Infections X Liu, W Luo, B Zhang, YG Lee, M Srinivasarao, P Low Available at SSRN 3821961, 0 | | |
